Diversified Healthcare Financials
DHCNL Stock | USD 16.20 0.84 5.47% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.62 | 1.2029 |
|
| |||||
Current Ratio | 12.05 | 11.4729 |
|
|
Investors should never underestimate Diversified Healthcare's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Diversified Healthcare's cash flow, debt, and profitability to make informed and accurate decisions about investing in Diversified Healthcare Trust.
Net Income |
|
Diversified | Select Account or Indicator |
Understanding current and past Diversified Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Diversified Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Diversified Healthcare's assets may result in an increase in income on the income statement.
Diversified Healthcare Stock Summary
Diversified Healthcare competes with DHCNI, Office Properties, QVCC, Brighthouse Financial, and QVC 6375. DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc., an alternative asset management company that is headquartered in Newton, MA. Diversified Healthcare is traded on NASDAQ Exchange in the United States.Specialization | Real Estate, Equity Real Estate Investment Trusts (REITs) |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
CUSIP | 81721M307 25525P305 |
Location | Massachusetts; U.S.A |
Business Address | Two Newton Place, |
Sector | Health Care REITs |
Industry | Real Estate |
Benchmark | Dow Jones Industrial |
Website | www.dhcreit.com |
Phone | 617 796 8350 |
Currency | USD - US Dollar |
Diversified Healthcare Key Financial Ratios
Return On Equity | -0.0606 | ||||
Profit Margin | (0.12) % | ||||
Operating Margin | 0.09 % | ||||
Revenue | 1.41 B | ||||
Gross Profit | 537.98 M |
Diversified Healthcare Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.7B | 6.5B | 6.6B | 6.0B | 5.4B | 4.2B | |
Net Debt | 3.5B | 3.5B | 3.0B | 2.4B | 2.6B | 1.9B | |
Cash | 37.4M | 74.4M | 634.8M | 658.1M | 245.9M | 258.2M | |
Other Assets | 159.5M | 6.1B | 5.7B | 5.1B | 75.3M | 71.5M | |
Net Receivables | 2.0M | 104.8M | 82.1M | 8.7M | 81.4M | 85.5M | |
Total Liab | 3.8B | 3.9B | 4.0B | 3.4B | 3.1B | 2.1B | |
Total Current Assets | 261.8M | 203.3M | 1.0B | 688.7M | 262.5M | 146.8M | |
Common Stock | 2.4M | 2.4M | 2.4M | 2.4M | 2.4M | 1.6M | |
Other Current Liab | 30.8M | (275.9M) | (770.2M) | (670.6M) | 22.9M | 24.0M | |
Retained Earnings | (1.9B) | (2.1B) | (2.0B) | (2.0B) | (2.3B) | (2.2B) | |
Inventory | 276.7M | 114.9M | 1.4B | (8.7M) | (10.0M) | (9.5M) | |
Other Current Assets | (54.2M) | (90.8M) | 382.1M | 39.3M | 16.6M | 30.8M | |
Short Term Debt | 537.5M | 303.2M | 800M | 700M | 1.8M | 1.7M | |
Intangible Assets | 337.9M | 286.5M | 48.7M | 45.4M | 33.9M | 32.3M | |
Net Tangible Assets | 2.6B | 2.6B | 2.4B | 2.2B | 2.0B | 2.0B | |
Long Term Debt | 3.7B | 3.5B | 3.0B | 3.5B | 4.0B | 3.2B | |
Long Term Debt Total | 3.7B | 3.5B | 3.0B | 3.5B | 4.0B | 3.2B | |
Capital Surpluse | 4.6B | 4.6B | 4.6B | 4.6B | 5.3B | 4.7B |
Diversified Healthcare Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Revenue | 1.0B | 1.6B | 1.4B | 1.3B | 1.4B | 1.5B | |
Gross Profit | 551.1M | 395.7M | 291.4M | 174.5M | 236.2M | 345.5M | |
Operating Income | 226.0M | 113.2M | 6.8M | (75.3M) | 4.1M | 3.9M | |
Ebit | 226.0M | (1.1B) | (748.5M) | (1.2B) | (76.8M) | (72.9M) | |
Ebitda | 515.0M | 383.3M | 708.2M | 164.0M | 207.3M | 332.4M | |
Net Income | (83.3M) | (134.3M) | 174.5M | (21.8M) | (293.6M) | (278.9M) | |
Income Tax Expense | 436K | 1.3M | 1.4M | 710K | 445K | 422.8K | |
Interest Expense | 180.1M | 201.5M | 255.8M | 209.4M | 191.8M | 137.0M | |
Income Before Tax | (82.8M) | (133.1M) | 181.4M | (21.1M) | (272.7M) | (259.0M) | |
Cost Of Revenue | 489.1M | 1.2B | 1.1B | 1.1B | 1.2B | 1.2B |
Diversified Healthcare Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (17.8M) | 38.6M | 926.1M | (328.6M) | (441.3M) | (419.3M) | |
Free Cash Flow | 265.8M | 158.5M | (63.3M) | (40.4M) | 10.5M | 11.0M | |
Depreciation | 282.2M | 262.7M | 263.9M | 239.5M | 284.1M | 151.4M | |
Dividends Paid | 199.7M | 42.8M | 9.5M | 9.6M | (9.6M) | (9.1M) | |
Capital Expenditures | 49.2M | 185.6M | 227.6M | 299.4M | 235.0M | 274.1M | |
Net Income | (82.9M) | (134.3M) | 179.9M | (15.8M) | (293.6M) | (278.9M) | |
End Period Cash Flow | 52.2M | 90.8M | 1.0B | 688.3M | 247.0M | 259.3M | |
Other Non Cash Items | 117.4M | 43.3M | (442.1M) | (265.7M) | 47.8M | 50.2M | |
Net Borrowings | (45.0M) | (77.0M) | (148.3M) | (14.2M) | (12.8M) | (12.1M) | |
Change To Netincome | (42.2M) | (189.3M) | 69.4M | 92.2M | 106.0M | 111.3M |
Diversified Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Diversified Healthcare's current stock value. Our valuation model uses many indicators to compare Diversified Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Diversified Healthcare competition to find correlations between indicators driving Diversified Healthcare's intrinsic value. More Info.Diversified Healthcare Trust is rated # 2 in return on equity category among its peers. It also is rated # 2 in return on asset category among its peers . At this time, Diversified Healthcare's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Diversified Healthcare by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Diversified Healthcare Systematic Risk
Diversified Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Diversified Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Diversified Healthcare correlated with the market. If Beta is less than 0 Diversified Healthcare generally moves in the opposite direction as compared to the market. If Diversified Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Diversified Healthcare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Diversified Healthcare is generally in the same direction as the market. If Beta > 1 Diversified Healthcare moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Diversified Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Diversified Healthcare's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Diversified Healthcare growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Diversified Healthcare November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Diversified Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Diversified Healthcare Trust. We use our internally-developed statistical techniques to arrive at the intrinsic value of Diversified Healthcare Trust based on widely used predictive technical indicators. In general, we focus on analyzing Diversified Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Diversified Healthcare's daily price indicators and compare them against related drivers.
Downside Deviation | 1.51 | |||
Information Ratio | (0.03) | |||
Maximum Drawdown | 10.24 | |||
Value At Risk | (2.44) | |||
Potential Upside | 4.72 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Diversified Healthcare Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Diversified Healthcare. If investors know Diversified will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Diversified Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.68) | Revenue Per Share 6.324 | Quarterly Revenue Growth 0.541 | Return On Assets 0.0124 | Return On Equity (0.06) |
The market value of Diversified Healthcare is measured differently than its book value, which is the value of Diversified that is recorded on the company's balance sheet. Investors also form their own opinion of Diversified Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Diversified Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Diversified Healthcare's market value can be influenced by many factors that don't directly affect Diversified Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Diversified Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Diversified Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Diversified Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.